Standard BioTools
LAB
LAB
155 hedge funds and large institutions have $273M invested in Standard BioTools in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
2.51% less ownership
Funds ownership: 78.71% → 76.2% (-2.5%)
3% less funds holding
Funds holding: 159 → 155 (-4)
29% less capital invested
Capital invested by funds: $387M → $273M (-$114M)
Holders
155
Holding in Top 10
2
Calls
$20K
Puts
$19K
Top Buyers
| 1 | +$8.33M | |
| 2 | +$4.04M | |
| 3 | +$2.46M | |
| 4 |
SCM
Sone Capital Management
New York
|
+$2.14M |
| 5 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
+$765K |
Top Sellers
| 1 | -$5.82M | |
| 2 | -$4.71M | |
| 3 | -$4.71M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$3.93M |
| 5 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$2.41M |
